Category Archives: Industry Headlines

Concentrics chairing CHPA Task Force to develop OTC Naming Guidance

Posted January 14th, 2015. Filed under Concentrics News, Industry Headlines

Julie Aker, President & CEO, is chairing the CHPA Task Force to develop an OTC Naming Guidance pursuant to comments on the Draft Proprietary Name Guidance.  To date, the Task Force has outlined key principles and explored various approaches to considering names for OTC drugs.  This work is expected to be completed by June 2015.

 

Comments submitted for Draft Proprietary Name Guidance

Posted November 10th, 2014. Filed under Concentrics News, Industry Headlines

Concentrics submitted written comments to the Docket for the Draft Proprietary Name Guidance.  We also submitted the results of a study that was  funded in part by CHPA, regarding “Consumer Navigation and Selection Behaviors for OTC Products.”  This pilot study showed that consumers use the brand name of the product to help them locate and select the products they need.

Concentrics Conducts Industry Research on How Consumer Navigate and Select OTC Products

Posted October 1st, 2014. Filed under Concentrics News, Industry Headlines

In support of changes to the draft FDA guidance on “Best Practices in Proprietary Names,” Concentrics designed and conducted a pilot study involving 200 consumers in order to learn how they navigate and select OTC products in a retail setting.  The data supports the importance of the brand name and trade dress to aid consumers in finding and selecting the OTC products they need.  The Consumer Healthcare Products Association (CHPA) contributed to the funding on this study.

You can request a copy of this paper by completing the contact form at the bottom of this page.

2/12/2014: Julie Aker, President & CEO, presented best practices and keys to success in a CHPA sponsored Webinar

Posted February 13th, 2014. Filed under Concentrics News, Industry Headlines

2/12/2014:
Julie Aker, President & CEO, presented best practices and keys to success in a CHPA sponsored Webinar;  Rx-to-OTC Switch Part II: How to Successfully Make the Switch.  Over 30 locations participated in the online webinar with an estimated 10 participants per location (~ 300 participants).  Participants asked great questions about how to develop a well-executed switch strategy.  Concentrics’ presentation materials can be requested by contacting doug.gorr@concentricsresearch.com.

Julie Aker to speak at RAPS Conference

Posted September 19th, 2013. Filed under Concentrics News, Industry Headlines

Julie Aker, President & CEO, has been invited to  speak at the RAPS (Regulatory Affairs Professional Society) Conference in Boston on September 30th to discuss the topic of Rx-to-OTC Switch.  Joining her on the panel will be
Ed Hemwall, PhD. From Merck Consumer Care.

Julie Aker, President & CEO, presentation at the Brookings Institution related to the Nonprescription Safe Use Regulatory Expansion (NSURE) initiative

Posted May 9th, 2013. Filed under Concentrics News, Industry Headlines

Julie Aker, President & CEO for Concentrics Research, was invited to be part of an expert panel, to discuss how consumers might benefit from using technology-assisted decision making.  Julie reviewed the types of decisions that consumers make when viewing a new over-the-counter (OTC) product and how technology might assist in these key decisions.  She also gave examples of how specific types of technology could be used at different stages of decision-making and to facilitate improve long-term compliance. Read more.